{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:53:45Z","timestamp":1783151625783,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-022-06065-7","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T09:22:57Z","timestamp":1642497777000},"page":"1569-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["New-onset Adult-onset Still\u2019s disease-like syndrome after ChAdOx1 nCoV-19 vaccination\u2014a case series with review of literature"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5369-7062","authenticated-orcid":false,"given":"Shivraj","family":"Padiyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-0739","authenticated-orcid":false,"given":"Navaneeth","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Chandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Shastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shashikala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-2724","authenticated-orcid":false,"given":"Arvind","family":"Ganapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"6065_CR1","unstructured":"Ritchie H, Mathieu E, Rod\u00e9s-Guirao L et al (2020) Coronavirus Pandemic (COVID-19). Our World in Data"},{"key":"6065_CR2","unstructured":"(2021) Covid vaccine: India administers more than one billion Covid jabs. BBC News"},{"key":"6065_CR3","unstructured":"Is the COVID-19 Vaccine Safe? https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/coronavirus\/is-the-covid19-vaccine-safe. Accessed 6 Jan 2022"},{"key":"6065_CR4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/annrheumdis-2021-220732","volume":"80","author":"M Barbhaiya","year":"2021","unstructured":"Barbhaiya M, Levine JM, Bykerk VP et al (2021) Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis 80:1352\u20131354. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220732","journal-title":"Ann Rheum Dis"},{"key":"6065_CR5","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1080\/21645515.2021.1920274","volume":"17","author":"Q-J An","year":"2021","unstructured":"An Q-J, Qin D-A, Pei J-X (2021) Reactive arthritis after COVID-19 vaccination. Hum Vaccin Immunother 17:2954\u20132956. https:\/\/doi.org\/10.1080\/21645515.2021.1920274","journal-title":"Hum Vaccin Immunother"},{"key":"6065_CR6","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","volume":"40","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40:2611. https:\/\/doi.org\/10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"key":"6065_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21:195\u2013197. https:\/\/doi.org\/10.1038\/s41577-021-00526-x","journal-title":"Nat Rev Immunol"},{"key":"6065_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti PM, Ewer KJ, Aley PK et al (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet 396:467\u2013478. https:\/\/doi.org\/10.1016\/S0140-6736(20)31604-4","journal-title":"Lancet"},{"key":"6065_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard J-L et al (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81:194\u2013200. https:\/\/doi.org\/10.1097\/00005792-200205000-00003","journal-title":"Medicine (Baltimore)"},{"key":"6065_CR10","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"key":"6065_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M et al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"6065_CR12","unstructured":"Hu Q, Zeng T, Sun C et al (2019) Clinical features and current treatments of adult-onset Still\u2019s disease: a multicentre survey of 517 patients in China. Clin Exp Rheumatol"},{"key":"6065_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","volume":"21","author":"Q Hu","year":"2019","unstructured":"Hu Q, Shi H, Zeng T et al (2019) Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still\u2019s disease. Arthritis Res Ther 21:9. https:\/\/doi.org\/10.1186\/s13075-018-1800-z","journal-title":"Arthritis Res Ther"},{"key":"6065_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40071","volume":"69","author":"EM Behrens","year":"2017","unstructured":"Behrens EM, Koretzky GA (2017) Review: Cytokine storm syndrome: looking toward the precision medicine era. Arthritis Rheumatol 69:1135\u20131143. https:\/\/doi.org\/10.1002\/art.40071","journal-title":"Arthritis Rheumatol"},{"key":"6065_CR15","doi-asserted-by":"publisher","first-page":"603389","DOI":"10.3389\/fimmu.2020.603389","volume":"11","author":"J Meng","year":"2020","unstructured":"Meng J, Ma Y, Jia J et al (2020) Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences. Front Immunol 11:603389. https:\/\/doi.org\/10.3389\/fimmu.2020.603389","journal-title":"Front Immunol"},{"key":"6065_CR16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2020-217618","volume":"79","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti P, Berardicurti O, Barile A et al (2020) Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? Ann Rheum Dis 79:1515\u20131516. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217618","journal-title":"Ann Rheum Dis"},{"key":"6065_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3389\/fimmu.2020.01130","volume":"11","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti P, Berardicurti O, Di Benedetto P et al (2020) Severe COVID-19, Another piece in the puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm. Front Immunol 11:1130. https:\/\/doi.org\/10.3389\/fimmu.2020.01130","journal-title":"Front Immunol"},{"key":"6065_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jbspin.2010.03.017","volume":"77","author":"W-H Yoo","year":"2010","unstructured":"Yoo W-H (2010) Adult onset Still\u2019s disease following influenza vaccination. Joint Bone Spine 77:373\u2013374. https:\/\/doi.org\/10.1016\/j.jbspin.2010.03.017","journal-title":"Joint Bone Spine"},{"key":"6065_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG (1971) Still\u2019s disease in the adult. Ann Rheum Dis 30:121\u2013133. https:\/\/doi.org\/10.1136\/ard.30.2.121","journal-title":"Ann Rheum Dis"},{"key":"6065_CR20","first-page":"818","volume":"33","author":"MA Balci","year":"2015","unstructured":"Balci MA, Pamuk \u00d6N, Pamuk GE et al (2015) Epidemiology and outcome of adult-onset Still\u2019s disease in Northwestern Thrace region in Turkey. Clin Exp Rheumatol 33:818\u2013823","journal-title":"Clin Exp Rheumatol"},{"key":"6065_CR21","doi-asserted-by":"crossref","unstructured":"Bamidis AD, Koehler P, di Cristanziano V et al (2021) First manifestation of adult-onset Still\u2019s disease after COVID-19. Lancet Rheumatol e319\u2013e321","DOI":"10.1016\/S2665-9913(21)00072-2"},{"key":"6065_CR22","doi-asserted-by":"publisher","first-page":"117954762199630","DOI":"10.1177\/1179547621996306","volume":"14","author":"A Alshablan","year":"2021","unstructured":"Alshablan A, Jabbad R, Tayeb S et al (2021) Diagnosis of Adult Onset Still\u2019s Disease in a patient who has recovered from coronavirus-19. Clin Med Insights Case Rep 14:1179547621996306. https:\/\/doi.org\/10.1177\/1179547621996306","journal-title":"Clin Med Insights Case Rep"},{"key":"6065_CR23","doi-asserted-by":"crossref","unstructured":"Baicus C, Delcea C, Pinte L, Dan GA (2021) Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still\u2019s disease. Does terminology matter? Rom J Intern Med","DOI":"10.2478\/rjim-2021-0035"},{"key":"6065_CR24","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","volume":"3","author":"F Leone","year":"2021","unstructured":"Leone F, Cerasuolo PG, Bosello SL et al (2021) Adult-onset Still\u2019s disease following COVID-19 vaccination. Lancet Rheumatol 3:e678\u2013e680. https:\/\/doi.org\/10.1016\/S2665-9913(21)00218-6","journal-title":"Lancet Rheumatol"},{"key":"6065_CR25","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","volume":"3","author":"D Magliulo","year":"2021","unstructured":"Magliulo D, Narayan S, Ue F et al (2021) Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine. Lancet Rheumatol 3:e680\u2013e682. https:\/\/doi.org\/10.1016\/S2665-9913(21)00219-8","journal-title":"Lancet Rheumatol"},{"key":"6065_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cmi.2017.151","volume":"15","author":"Y Segal","year":"2018","unstructured":"Segal Y, Shoenfeld Y (2018) Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol 15:586\u2013594. https:\/\/doi.org\/10.1038\/cmi.2017.151","journal-title":"Cell Mol Immunol"},{"key":"6065_CR27","doi-asserted-by":"publisher","unstructured":"Khan S, Shafiei MS, Longoria C et al (2021) SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. bioRxiv 2021.03.16.435700. https:\/\/doi.org\/10.1101\/2021.03.16.435700","DOI":"10.1101\/2021.03.16.435700"},{"key":"6065_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","volume":"31","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Kuang M, Li J et al (2021) SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res 31:818\u2013820. https:\/\/doi.org\/10.1038\/s41422-021-00495-9","journal-title":"Cell Res"},{"key":"6065_CR29","first-page":"6502373","volume":"2016","author":"R Gopalarathinam","year":"2016","unstructured":"Gopalarathinam R, Orlowsky E, Kesavalu R, Yelaminchili S (2016) Adult-onset Still\u2019s disease: a review on diagnostic workup and treatment options. Case Rep Rheumatol 2016:6502373","journal-title":"Case Rep Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06065-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06065-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:23:47Z","timestamp":1744154627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06065-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6065"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06065-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent has been obtained from all the patients before preparing this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"AG reports receiving an honorarium for an invited guest lecture from Chugai Pharmaceuticals, Japan, outside the scope of this study. SP, NK, JM CAS, DD, BAS, and ST have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}